Home
Drugs
Pomalidomide
Clinical Trials

Clinical Trials Related to Pomalidomide

Related studies linked through entity extraction aliases.

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma

Status: TERMINATED
Phase: PHASE2

Pom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Treatment

Status: TERMINATED
Phase: PHASE3

A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)

Status: COMPLETED
Phase: PHASE1/PHASE2

A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Status: TERMINATED
Phase: PHASE1

A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

Status: COMPLETED
Phase: PHASE2

An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma

Status: WITHDRAWN
Phase: PHASE2

Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma

Status: COMPLETED
Phase: PHASE2

Comparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/Dex

Status: COMPLETED
Phase: PHASE3

A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma

Status: COMPLETED
Phase: PHASE2

A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide

Status: TERMINATED
Phase: PHASE3

Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma

Status: COMPLETED
Phase: PHASE1

Combination Study for High Risk Multiple Myeloma Patients

Status: TERMINATED
Phase: PHASE2

Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma

Status: TERMINATED
Phase: PHASE1

Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients

Status: COMPLETED
Phase: PHASE3

Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma

Status: COMPLETED
Phase: PHASE1

Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma

Status: UNKNOWN
Phase: PHASE3

A Study to Determine the Safety and Efficacy for the Combination of Durvalumab and Daratumumab in Relapsed and Refractory Multiple Myeloma

Status: TERMINATED
Phase: PHASE2

An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma

Status: COMPLETED
Phase: PHASE3